Trial Profile
A 1-Month, Prospective, Multicenter, Randomized, Dose-Ranging, Sham-Controlled, Blinded Study of OTO-201 Given as a Single Administration for Treatment of Acute Otitis Media With Tympanostomy Tubes in Pediatric Subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Oct 2020
Price :
$35
*
At a glance
- Drugs Ciprofloxacin (Primary)
- Indications Otitis media
- Focus Adverse reactions
- Sponsors Otonomy [CEASED]
- 03 Aug 2017 According to an Otonomy media release, results from this study were presented at the American Society of Pediatric Otolaryngology (ASPO) Annual Meeting 2017.
- 12 May 2017 According to an Otonomy media release, data will be presented at the American Society of Pediatric Otolaryngology (ASPO) Annual Meeting 2017.
- 04 Oct 2016 According to an Otonomy media release, additional results from this trial will be presented at the Otonomy Investor and Analyst Day on October 7 and at an upcoming medical conference.